Asia-Pacific
Vivien Chan joins us for our ‘Women in IP’ series to discuss gender bias in the legal profession and why the business model followed by law firms leaves little room for women leaders
Greg Munt, who has moved from Griffith Hack to James & Wells after four decades, hails his new firm’s approach to client service
Alif Gultom and Andrew Diamond of Januar Jahja & Partners explain why Indonesia must adopt reforms against bad-faith filings and safeguard its trademark system for the future
Find out which firms secured the most nominations for Managing IP’s Asia-Pacific Awards 2025, ahead of the winners being revealed on November 6
Sponsored
Sponsored
-
Sponsored by Liu, Shen & AssociatesHongbo Jia of Liu, Shen & Associates examines recent Supreme People’s Court cases that reshape Chinese patent litigation in addressing damages, patent validity, and pre-litigation injunctions, with important implications for multinational businesses -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains an Intellectual Property High Court decision addressing the applicability of the abuse of right doctrine in a design invalidation action
-
Sponsored by Tilleke & GibbinsLoc Xuan Le, Giang Hoang Bach, and Duc Anh Tran of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins, report on a rare challenge to a non-use cancellation
-
Sponsored by Saint Island International Patent & Law OfficesSumin Lai of Saint Island International Patent & Law Offices outlines how the decisions offer valuable insights into inventive step assessment in Taiwanese patent disputes
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Anita Rawat of RNA, Technology and IP Attorneys address the main questions concerning India’s regulation of greenwashing across advertising, financial products, and the food sector
-
Sponsored by Wanhuida Intellectual PropertyAs an AstraZeneca patent survives a tenth invalidation challenge in China, Jianhui Li of Wanhuida Intellectual Property considers the implications for generic drug makers and the pharmaceutical industry
